Chapter One, requesting subscriptions and monthly votes~~
...
Although there was a small internal problem at Reid Pharmaceuticals, Qin Fang still reached a preliminary cooperation agreement with Helen about this partnership.
Overall, Qin Fang would provide the technology, while Reid Pharmaceutical Group would provide the funds and equipment, in exchange for the sales rights in Europe and America.
Regarding profit-sharing, naturally, Qin Fang would take the majority, about seventy percent, while Reid Pharmaceutical Group would only get about thirty percent but would still receive considerable benefits.
After all, Reid Pharmaceuticals is a globally renowned enterprise, possessing strong backup forces, abundant funds, complete infrastructure, and well-established sales channels… these are all things Qin Fang lacks.
